Securities code: 300601 securities abbreviation: Shenzhen Kangtai Biological Products Co.Ltd(300601) Announcement No.: 2022-011
Bond Code: 123119 bond abbreviation: Kangtai Zhuan 2
Shenzhen Kangtai Biological Products Co.Ltd(300601)
About the first grant of stock options under the 2019 stock option incentive plan
The second exercise period adopts the suggestive announcement of independent exercise mode
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records
Misleading statements or material omissions.
Shenzhen Kangtai Biological Products Co.Ltd(300601) (hereinafter referred to as the “company”) on January 28, 2022
The second meeting of the seventh board of directors and the second meeting of the seventh board of supervisors were held on August, and the meeting deliberated and adopted the
Discussion on the achievement of exercise conditions in the second exercise period of stock options first granted under the stock option incentive plan in 2019
It is agreed that 473 incentive objects will exercise their rights in the way of independent exercise in the second exercise period, and the shares can be exercised
The total number of options is 13268650, accounting for 1.93% of the total share capital of the company. For details, please refer to the company’s
On the first grant of 2019 stock option incentive plan disclosed on cninfo.com on January 28, 2022
Announcement on the achievement of exercise conditions in the second exercise period of stock options.
As of the disclosure date of this announcement, the independent exercise has been reviewed and approved by Shenzhen Stock Exchange, and the public
The company has completed the registration and declaration of independent exercise in Shenzhen Branch of China Securities Depository and Clearing Co., Ltd
Work. The relevant matters are hereby announced as follows:
1、 Specific arrangements for independent exercise of rights
1. Option abbreviation: Kangtai jlc1
2. Option Code: 036359
3. Source and type of stock for exercise: the company issues A-share common stock to the incentive object
4. Number of exercisable incentive objects and exercisable options:
Granted stock period exercised stock period exercisable stock period in current period number of stock options (10000) (10000) stock options (10000) that do not meet the name of the exercise clause number of job rights (10000)
Liu Jiankai, director and vice president 40.000 20.000 20.000 0
Core technical personnel
(business) personnel (472 persons)
Total 2670.100 1288.625 1326.865 8.185
Note: in the first exercise period, some incentive objects do not meet the exercise conditions due to their assessment not reaching good or above
The option has been cancelled by the company, and the total number of cancelled options is 4642500. In the second exercise period, 818500 stock options of some incentive objects that cannot be exercised because the assessment is not good or above will be cancelled by the company.
The shares held by Liu Jiankai, the director and vice president of the company after exercising his rights, will be implemented in accordance with the company law, the rules for the management of shares and changes of the company held by directors, supervisors and senior managers of listed companies and other relevant laws and regulations. It has issued a commitment not to transfer its shares of the company within 6 months after the exercise.
5. Exercise price: 44.24 yuan / share. In case of conversion of capital reserve into share capital, distribution of stock dividends, share splitting or reduction, allotment and other matters before the incentive object exercises, the exercise price and exercise quantity of stock options will be adjusted accordingly.
6. Exercise method: independent exercise.
7. Exercise period: according to the actual situation of independent exercise business, the actual exercisable period is from February 15, 2022 to April 28, 2022. The incentive object must complete the exercise within the validity period of the option,
After the expiration of the exercise period, the stock options that have not been exercised will automatically expire and be cancelled by the company.
8. Exercisable date: the exercisable date must be a trading day, but may not be exercised within the following periods:
(1) Within 30 days before the announcement of the company’s periodic report, if the announcement date of the periodic report is delayed due to special reasons, it shall be calculated from 30 days before the original scheduled announcement date to the day before the announcement;
(2) Ten days before the announcement of the company’s performance forecast and performance express;
(3) Within two days from the date of disclosure of major events that may have a significant impact on the stock price of the company or the date of entering into the derivative trading procedures according to law;
(4) Other periods prescribed by the CSRC and Shenzhen Stock Exchange.
9. The funds raised in this exercise will be deposited in the special account for exercise to supplement the company’s working capital. The individual income tax paid by the stock option exercisable incentive object shall be withheld and paid by the company.
2、 Impact of this exercise on the company
1. Impact on the company’s ownership structure and listing conditions
This exercise will not have a significant impact on the equity structure of the company, and the controlling shareholder and actual controller of the company will not change. After the end of the second exercise period of stock options granted for the first time in this incentive plan, the equity distribution of the company still meets the listing conditions.
2. Impact on the company’s financial status and operating results in the current year
The stock option expenses related to this exercise are amortized within the waiting period in accordance with the relevant accounting standards and accounting systems, included in the relevant costs and expenses, and the capital reserve is increased accordingly. Assuming that all the exercisable stock options in this period are exercised, the total share capital of the company will increase by 1326865 shares, which will affect and dilute the basic earnings per share and return on net assets of the company. The specific impact is subject to the data audited by accountants.
3. The influence of choosing independent exercise mode on stock option valuation method
On the grant date, the company adopts the Black Scholes option pricing model to determine the fair value of stock options on the grant date, which has been amortized during the waiting period of the equity incentive plan. The independent exercise mode adopted this time will not have a material impact on the option valuation method and the company’s financial status and operating results.
3、 Other matters
1. The company has signed the equity incentive independent exercise service agreement with the securities firm China Securities Co.Ltd(601066) undertaking the independent exercise, and clearly agreed on the rights and obligations of all parties. In the commitment letter of equity incentive independent exercise business, the undertaking securities firm promised that the independent exercise business system provided to the company and incentive objects fully met the independent exercise business operation and relevant compliance requirements.
2. The company will disclose quarterly changes in equity incentive objects, adjustment of important parameters of stock options, independent exercise of incentive objects and changes in shares of the company in regular reports or in the form of interim reports.
It is hereby announced.
Shenzhen Kangtai Biological Products Co.Ltd(300601) board of directors February 11, 2022
